Intratumoral Immunotherapy for Cancer: Update 2024 of a Novel Approach

10 Views
Published
David G. Bostwick, MD, MBA, FCAP, Triopsy Medical, LLC, Orlando, Florida, discusses the potential of intratumoral immunotherapy in treating prostate cancer and other challenging malignancies. In this 19-minute presentation, Dr. Bostwick explores multiplex immunotherapy as a promising avenue for traditionally immunologically resistant cancers like prostate cancer. His presentation inspires optimism for advancing treatment strategies through innovative immune-based approaches.
Category
Oncology
Be the first to comment